California Public Employees Retirement System’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

California Public Employees Retirement System’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-10,562	Closed	-$103K	–	3382
2017 Q2	$103K	Hold	10,562	–	–	﹤0.01%	3172
2017 Q1	$256K	Sell	10,562 -458	-4%	-$11.5K	﹤0.01%	2933
2016 Q4	$354K	Hold	11,020	–	–	﹤0.01%	2849
2016 Q3	$551K	Sell	11,020 -762	-6%	-$31.6K	﹤0.01%	2674
2016 Q2	$500K	Sell	11,782 -369	-3%	-$20.1K	﹤0.01%	2720
2016 Q1	$800K	Sell	12,151 -750	-6%	-$39.1K	﹤0.01%	2476
2015 Q4	$802K	Hold	12,901	–	–	﹤0.01%	2523
2015 Q3	$864K	Hold	12,901	–	–	﹤0.01%	2455
2015 Q2	$1.25M	Hold	12,901	–	–	﹤0.01%	2362
2015 Q1	$1.01M	Hold	12,901	–	–	﹤0.01%	2574
2014 Q4	$1.01M	Buy	+12,901	New	+$940K	﹤0.01%	2574
2013 Q4	–	Sell	-496	Closed	-$15K	–	4083
2013 Q3	$15K	Buy	496 +420	+553%	+$14.7K	﹤0.01%	3796
2013 Q2	$4K	Buy	+76	New	+$3.33K	﹤0.01%	3938

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

California Public Employees Retirement System's MACK Position: Q3 2017 in Review

California Public Employees Retirement System sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2017, closing a stake of 10,562 shares — an estimated $103K sold.

California Public Employees Retirement System first reported a position in MACK in Q2 2013 and held it in 13 quarters. The position peaked at $1.25M in Q2 2015. 73 funds tracked by Wall St. Rank hold MACK as of Q3 2017.

California Public Employees Retirement System reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
California Public Employees Retirement System sold 10,562 Merrimack Pharmaceuticals, Inc. shares in Q3 2017, an estimated $103K.
California Public Employees Retirement System first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 13 quarters.
California Public Employees Retirement System's Merrimack Pharmaceuticals, Inc. position peaked at $1.25M in Q2 2015.
73 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2017.

Based on California Public Employees Retirement System's 13F filing for Q3 2017, filed 15 Nov 2017.